Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20
years shorter than that in the general population. The rate of unnatural deaths, such as …

People with severe mental illness (SMI)–schizophrenia, bipolar disorder and major
depressive disorder–appear at risk for cardiovascular disease (CVD), but a comprehensive …

Page 1 World mental health report Transforming mental health for all World Health Organization
Page 2 Page 3 World Health Organization World mental health report Transforming mental health …

The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

Antipsychotics are effective in preventing relapses of schizophrenia, but it is generally
believed that their long‐term use is harmful for patients' physical well‐being. However, there …

Psychiatric genetics has made substantial progress in the last decade, providing new
insights into the genetic etiology of psychiatric disorders, and paving the way for precision …

Background The benefits and risks of augmenting or switching antidepressants in older
adults with treatment-resistant depression have not been extensively studied. Methods We …

Coronary heart disease (CHD) and mental illness are among the leading causes of
morbidity and mortality worldwide. Decades of research has revealed several, and …

Abstract Purpose of Review To describe the presentation, etiologies, and suggested
management of post-acute COVID-19 neuropsychiatric symptoms. Recent Findings Over …

Depression is widely acknowledged to be a heterogeneous entity, and the need to further
characterize the individual patient who has received this diagnosis in order to personalize …